Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target…

Overview of attention for article published in The Lancet, October 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 34 news outlets
blogs: 3 blogs
twitter: 41 X users
facebook: 1 Facebook page

wikipedia: 2 Wikipedia pages
video: 1 YouTube creator
guideline: 2 clinical guideline sources
podcasts: 2 podcasts

Readers on

mendeley: 104 Mendeley

So far, Altmetric has seen 39 news stories from 34 outlets.

First Once-Weekly Basal Insulin Approved for Type 2 Diabetes

MedPage Today, 27 Mar 2026

Awiqli succeeds in type 2 after faltering in type 1 population by, Senior Staff Writer, MedPage Today March 27, 2026 • 2 min…

Once-weekly insulin might mean fewer shots for some with diabetes

Science News, 22 Oct 2024

Aimee Cunningham is the biomedical writer. She has a master’s degree in science journalism from New York University.

Weekly Insulin Efsitora Noninferior to Daily Degludec in Type 1, Type 2 Diabetes

MedPage Today, 10 Sep 2024

Meeting Coverage > EASD But higher severe hypoglycemia risk with efsitora in type 1 diabetes likely precludes its use by…

Is real-time blood sugar control becoming a reality with smart insulin?

Medical News Today, 26 Aug 2024

People with type 1 diabetes must monitor their blood glucose levels and inject precise doses of insulin several times a day to…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 35 additional news stories.